Praveen Anand Selected Research

TRPV Cation Channels

1/2018	Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons.
9/2008	Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons.
5/2007	Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy.
8/2006	Transient receptor potential vanilloid receptor subtype 1 in painful bladder syndrome and its correlation with pain.
3/2005	Increased capsaicin receptor TRPV1 in skin nerve fibres and related vanilloid receptors TRPV3 and TRPV4 in keratinocytes in human breast pain.
9/2004	Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Praveen Anand Research Topics

Disease

31	Pain (Aches) 10/2021 - 01/2002
16	Neuralgia (Stump Neuralgia) 10/2021 - 01/2004
10	Hypersensitivity (Allergy) 01/2021 - 04/2005
8	Chronic Pain 04/2021 - 08/2007
7	Inflammation (Inflammations) 06/2014 - 01/2004
6	Neoplasms (Cancer) 01/2022 - 01/2019
5	Hyperalgesia 10/2015 - 01/2004
4	Diabetic Neuropathies (Diabetic Neuropathy) 10/2021 - 01/2004
4	Interstitial Cystitis (Interstitial Cystitis, Chronic) 12/2006 - 03/2006
3	Postherpetic Neuralgia 10/2021 - 05/2014
3	COVID-19 01/2021 - 01/2020
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 01/2019
3	Arthritis (Polyarthritis) 09/2018 - 08/2011
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 02/2003
2	Multiple Sclerosis 09/2018 - 06/2010
2	Nociceptive Pain 01/2016 - 04/2009
2	Burning Mouth Syndrome (Syndrome, Burning Mouth) 08/2010 - 06/2010
2	Abdominal Pain (Pain, Abdominal) 06/2010 - 02/2003
2	Neuroma 09/2008 - 01/2006
2	Allergic Rhinitis 04/2008 - 09/2007
2	Rhinitis 04/2008 - 09/2007
2	Hematuria 07/2006 - 03/2006
1	Multiple Myeloma 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Fatigue 01/2021
1	Headache (Headaches) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Cold Injury 01/2021
1	Myalgia 01/2021
1	Infections 01/2020
1	Cancer Pain 09/2018
1	Somatoform Disorders (Somatoform Disorder) 09/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Phantom Limb (Phantom Limbs) 01/2017
1	Pruritus (Itching) 05/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2015
1	Peripheral Nerve Injuries 04/2015
1	Radiculopathy (Radiculopathy, Cervical) 04/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2014
1	Vascular Remodeling 06/2014

Drug/Important Bio-Agent (IBA)

15	Capsaicin (Zostrix)FDA Link 01/2021 - 04/2004
8	Nerve Growth Factor (NGF)IBA 01/2021 - 01/2004
7	Analgesics (Analgesic Drugs)IBA 10/2021 - 08/2007
6	Voltage-Gated Sodium ChannelsIBA 10/2018 - 01/2002
6	TRPV Cation ChannelsIBA 01/2018 - 09/2004
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2007
5	Ion Channels (Ion Channel)IBA 05/2015 - 11/2007
5	AntibodiesIBA 04/2008 - 02/2003
4	Type 2 Angiotensin ReceptorIBA 10/2021 - 05/2014
4	EMA400IBA 10/2021 - 05/2014
4	TRPV1 receptorIBA 01/2020 - 04/2004
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2007
3	Sodium Channels (Sodium Channel)IBA 01/2011 - 04/2008
2	CannabinoidsIBA 04/2021 - 06/2010
2	Small Cytoplasmic RNAIBA 01/2021 - 01/2020
2	Peptides (Polypeptides)IBA 01/2020 - 01/2016
2	Therapeutic UsesIBA 01/2020 - 01/2006
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2020 - 01/2004
2	Nerve Growth Factors (Neurotrophins)IBA 01/2020 - 01/2004
2	Pharmaceutical PreparationsIBA 02/2016 - 12/2006
2	Angiotensin IIIBA 02/2016 - 06/2015
2	LigandsIBA 01/2016 - 06/2015
2	p38 Mitogen-Activated Protein KinasesIBA 04/2015 - 11/2011
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 06/2010 - 09/2008
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	ChromatinIBA 11/2021
1	Medical MarijuanaIBA 04/2021
1	Dronabinol (THC)FDA LinkGeneric 01/2021
1	Calcium Gluconate (CBG)IBA 01/2021
1	VaccinesIBA 01/2021
1	NAD (NADH)IBA 01/2021
1	Nucleic AcidsIBA 01/2020
1	HLA-A Antigens (HLA-A)IBA 01/2020
1	CannabidiolIBA 01/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2018
1	Purinergic AgonistsIBA 01/2018
1	Angiotensin II Type 2 Receptor BlockersIBA 02/2016
1	Peptide Receptors (Peptide Receptor)IBA 01/2016
1	NociceptinIBA 01/2016
1	Opioid Receptors (Opioid Receptor)IBA 01/2016
1	AntigensIBA 10/2015
1	GAP-43 Protein (GAP 43 Protein)IBA 10/2015
1	6- amino- 5- (2,3,5- trichlorophenyl)pyridine- 2- carboxylic acid methylamideIBA 05/2015
1	Phosphotransferases (Kinase)IBA 05/2015
1	pegcantratinibIBA 05/2015
1	TropomyosinIBA 05/2015
1	CalciumIBA 05/2015
1	6- (5- ((cyclopropylamino)carbonyl)- 3- fluoro- 2- methylphenyl)- N- (2,2- dimethylprpyl)- 3- pyridinecarboxamideIBA 04/2015

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2002
4	Drug Therapy (Chemotherapy) 01/2021 - 08/2008
2	Analgesia 02/2016 - 01/2004
1	Precision Medicine 12/2021
1	Aftercare (After-Treatment) 01/2021
1	Prostheses and Implants (Prosthesis) 01/2017
1	Surgical Amputation (Amputations) 01/2017